Clinical Trials Browser

Terminated × Interventional × Peripheral Nervous System Diseases × Clear all

Breast Neoplasms, Motor Activity, Peripheral Nervous System Diseases

NCT04034355 2022-01-26

POLAR-A

Phase 3 Terminated

301 enrolled 18 charts

Gastrointestinal

Neoplasms, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT04558034 2021-03-08

The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer

Phase NA Terminated

14 enrolled

Peripheral Nervous System Diseases

NCT01783522 2019-10-22

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Phase 2 Terminated

9 enrolled 10 charts

Plasma cell

Multiple Myeloma, Peripheral Nervous System Diseases

NCT01243541 2019-08-20

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

Phase NA Terminated

33 enrolled

Breast

Breast Neoplasms, Pain, Peripheral Nervous System Diseases

NCT02795572 2019-07-05

CIPN

Phase 2 Terminated

13 enrolled

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT03206216 2018-12-19

Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN

Phase NA Terminated

1 enrolled 5 charts

Gynecologic

Hypesthesia, Ovarian Neoplasms, Pain, Paresthesia, Peripheral Nervous System Diseases, Acute Pain

NCT00267007 2014-06-04

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Phase 2 Terminated

32 enrolled 9 charts

Neoplasms, Peripheral Nervous System Diseases

Clinical Trials

HOPE

POLAR-A

The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

CIPN

Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy